
ECBF joins Novo Seeds and Sofinnova Partners in EUR11.5m round in Biosyntia
Using cutting-edge biotechnology and proprietary R&D tools and insights, the company is developing first-of-its-kind precision fermentation...

Immunocore has a sip with USD140m private placement
Immunocore Holdings plc (Nasdaq: IMCR), a biotechnology company pioneering the development of a novel class of T cell receptor (TCR) bispecific...

Sartorius pays £415m for Albumedix Ltd
Investors in biopharma equipment supplier Sartorius SE truly cannot complain about a poor news flow. Now, the fermenters and media specialists are...

Oxford Science Enterprises raised a further £250 million ($300 million) in funding
These funds enable OSE to identify further exceptional science from the University of Oxford, providing initial funding, hands-on support and access...

French-German Novasep-PharmaZell Group invests EUR7.3M at Mourenx site
The Novasep-PharmaZell Group has announced a €7.3M investment for its Mourenx site (southwestern France), as part of a larger project supported by...

French ImCheck get´s a USD103m check by Pfizer and a pack of VCs
With around EUR100m in previous financing rounds ImCheck’s financial position looks 'solidified' to take on the leadership in the gamma-delta T cell...

Orphan drug developer Minoryx raises €51m
The Series C round was co-led by Columbus Venture Partners and Caixa Capital Risc, and supported by CDTI Innvierte, Fund+, Ysios Capital and other...